The tuna meat is a nutritious food that possesses high content of protein, its low content of saturated fatty acids makes it a high demand food in the world. The Thunnus genus is composed of eight species, albacore (T. alalunga), bigeye (T. obesus), long tail tuna (T. tonggol), yellowfin tuna (T. albacares), pacific bluefin tuna (T. orientalis), bluefin tuna (T. maccoyii), Atlantic bluefin tuna ( T. thynnus) and blackfin tuna (T. atlanticus). The blackfin tuna (BFT) (Thunnus atlanticus) represent the smallest species within the Thunnus genus. This species inhabits the warm waters of the West Atlantic Ocean, from the shore of Massachusetts in the north, to Rio De Janeiro in Brazil. The first objective of this study was to evaluate the nutritional composition of BFT captured in the Gulf of Mexico, we determined ash, moisture, fat, protein and carbohydrates in BFT muscle and compared the obtained data with the nutritional reports from commercial tuna species including yellowfin tuna, Atlantic bluefin tuna and salmon (Salmo salar). Secondly, we report the genetic diversity and genetic differentiation of BFT within its geographical distribution range using the Cytochrome Oxidase I (COI) and control region sequenced data and from specimens collected in the Gulf of Mexico. We observed a nucleotide diversity π=0.001, 24 segregating sites and 10 parsimony informative. Within the CR we found nine different haplotypes π=0.044, 39 segregating sites, 16 parsimony informative sites. We concluded that according with the haplotype distribution there are differences among the BFT from the Gulf of Mexico and the North Atlantic compared to the South Atlantic. The Caribbean Sea is a migration point of the BFT, where all except the South Atlantic haplotypes were found.

Mexicans and Mexican Americans share culture, genetic background, and predisposition for chronic complications associated with obesity and diabetes making imperative efficacious treatments and prevention. Obesity has been treated for centuries focused-on weight loss while other treatments on associated conditions like gout, diabetes (T2D), and hypertriglyceridemia. To date, there is no systematic review that synthetize the origin of obesity clinics in Mexico and the efforts to investigate treatments for obesity tested by randomized clinical trials (RCT). We conducted systematic searches in Pubmed, Scopus, and Web of Science to retrieve anti-obesity RCT through 2019 and without inferior temporal limit. The systematic review included RCT of anti-obesity treatments in the Mexican adult population, including alternative medicine, pharmacological, nutritional, behavioral, and surgical interventions reporting biometric outcomes such as BMI, weight, waist circumference, triglycerides, glucose, among others. Studies with at least three months of treatment were included in the meta-analysis. We found 634 entries, after removal of duplicates and screening the studies based on eligibility criteria, we analyzed 43, and 2 multinational-collaborative studies. Most of the national studies have small sample sizes, and the studied strategies do not have replications in the population. The nutrition/behavioral interventions were difficult to blind, and most studies have medium to high risk of bias. Nutritional/behavioral interventions and medications showed effects on BMI, waist circumference, and blood pressure. Simple measures like plain water instead of sweet beverages decrease triglycerides and systolic blood pressure. Participants with obesity and hypertension can have benefic effects with antioxidants, and treatment with insulin increase weight in those with T2D. The study of obesity in Mexico has been on-going for more than four decades, but the interest on RCT just increased until this millennium, but with small sample sizes and lack of replication. The interventions affect different metabolic syndrome components, which should be analyzed in detail with the population living on the U.S.-Mexico border; therefore, bi-national collaboration is desirable to disentangle the cultural effects on this population's treatment response.